Item 301 | First Year - FY2023 | Second Year - FY2024 |
|---|---|---|
| Regulation of Professions and Occupations (56000) | $37,784,871 | $38,667,396 |
| Technical Assistance to Regulatory Boards (56044) | FY2023 $37,784,871 | FY2024 $38,667,396 |
| Fund Sources: | ||
| Trust and Agency | FY2023 $1,450,565 | FY2024 $1,450,565 |
| Dedicated Special Revenue | FY2023 $36,334,306 | FY2024 $37,216,831 |
Authority: Title 54.1, Chapter 25, Code of Virginia.
A. Nurse practitioners licensed in the Commonwealth of Virginia, except those licensed in the category of Certified Registered Nurse Anesthetists, with two or more years of clinical experience may continue to practice in the practice category in which they are certified and licensed and prescribe without a written or electronic practice agreement until the termination of a declared state of emergency due to the COVID-19 pandemic.
B. Notwithstanding any other provision of this Act or any other provision of law, a pharmaceutical processor license shall permit such licensee to cultivate and manufacture out of a single establishment location, except that a cannabis establishment changing its cultivation and manufacturing location may operate at both the former and new location during the site transition process which shall last no more than the life of this Act. Prior to operating an additional cultivation and manufacturing establishment at a different location, a licensee shall be inspected by the Board of Pharmacy in accordance with this Act.